Rocket


News + Filings


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Mallinckrodt Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
12/06/2022 RW Form RW - Registration Withdrawal Request:
06/27/2019 10-12B/A Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
05/21/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Mallinckrodt Files Suit against U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services to Protect Medicaid Patient Access to Acthar® Gel — Company challenges CMS' unexplained and unlawful reversal of its repeated 2012 written authorizations on calculation of Medicaid Rebates for Acthar Gel — — After extensive efforts to resolve matter, Mallinckrodt seeks Court intervention to ensure that CMS follows Administrative Procedure Act and other legal requirements — — Without Court intervention, Acthar Gel Medicaid net sales, currently ~10% of total, would be eliminated by CMS' decision, placing drug's previous net sales 2019 guidance of >$1.0 billion at risk, with the potential for retroactive non-recurring charges of $0 to $600 million — Company plans vigorou..."
05/10/2019 10-12B/A Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy